Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William I. Bensinger, MD
Fred Hutchinson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
Los Angeles, California, United States
- Desert Regional Medical Center Comprehensive Cancer Center
Palm Springs, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus
Boca Raton, Florida, United States
- St. Vincent'S Comprehensive Cancer Center - Manhattan
New York, New York, United States
- Oregon Health and Science University Cancer Institute
Portland, Oregon, United States
- Lone Star Oncology - Austin
Austin, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2006
- Primary completion
- 31 Dec 2008
- Completion
- —
- Last update posted
- 13 Mar 2009
- Registered enrollment
- 43
- Registry id
- NCT00438841
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.